Evidence map›Paper›PMID 35330485›Full record

ArticleJournal of personalized medicine2022

Depression, Insomnia and Post-Traumatic Stress Disorder in COVID-19 Survivors: Role of Gender and Impact on Quality of Life.

Sofia Pappa, Zafeiria Barmparessou, Nikolaos Athanasiou, Elpitha Sakka, Kostas Eleftheriou, Stavros Patrinos, Nikolaos Sakkas, Apostolis Pappas, Ioannis Kalomenidis, Paraskevi Katsaounou

Open access · goldAbstract read
In one paragraph

Article in Journal of personalized medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Sofia PappaDepartment of Brain Sciences, Imperial College London, London W12 0NN, UK.ORCID 0000-0002-6303-1547
Zafeiria BarmparessouPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Nikolaos AthanasiouPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Elpitha SakkaSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4AT, UK.
Kostas EleftheriouPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Stavros PatrinosPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Nikolaos SakkasFaculty of Medicine, University of Warwick, Coventry CV4 7AL, UK.
Apostolis PappasPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Ioannis KalomenidisPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.
Paraskevi KatsaounouPulmonary and Respiratory Failure Department, First ICU, Evangelismos Hospital, 106 76 Athens, Greece.ORCID 0000-0002-8736-619X
Evangelismos Hospital · GRNational and Kapodistrian University of Athens · GRImperial College London · GBUniversity of Brighton · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence to date suggests that a significant proportion of COVID-19 patients experience adverse psychological outcomes and neuropsychiatric complications. The aim of this study was to evaluate the effect of SARS-CoV-2 infection and subsequent hospitalization on the mental health, sleep, and quality of life of COVID-19 survivors. Patients were assessed 1−2 months after hospital discharge using standardized screening tools for depression and anxiety (HADS), post-traumatic stress disorder (IES-R), insomnia (AIS), and quality of life (EQ-5D-5L). Sociodemographic factors, comorbidities, disease severity and type of hospitalization were also collected. Amongst the 143 patients included, mental health symptoms were common (depression—19%; anxiety—27%; traumatic stress—39%; insomnia—33%) and more frequently reported in female than in male patients. Age, smoking status, comorbidities and illness severity were not found to significantly correlate with the presence of mood, sleep, or stress disorders. Finally, quality of life was worse for patients requiring ICU (p = 0.0057) or a longer hospital stay (p < 0.001) but was unaffected by factors such as sex and other measured outcomes. These findings highlight the need for appropriate intervention to properly manage the immediate and enduring mental health complications of COVID-19.

Indexed as

anxietyCOVID-19depressionmental healthpatientsPTSDquality of lifesex differencessleep

Identifiers

PMID35330485
PMCPMC8950533
OpenAlexW4220675925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.